¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°Ç±¹´ëÇб³º´¿ø Konkuk Live Symposium: APECS, 2018 : 2018-11-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°Ç±¹´ëÇб³º´¿ø Konkuk Live Symposium: APECS, 2018 : 2018-11-25
±³À°ÀÏÀÚ : 2018-11-25
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ´ë°­´ç(B3)  
±³À°ÁÖÁ¦ : Konkuk Live Symposium: APECS, 2018 
ÁÖÃÖ±â°ü : °Ç±¹´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ»óÀÇÇаú  
´ã´çÀÚ : ÇÔ»óÇù
¿¬¶ôó : 02-3144-2227  
À̸ÞÀÏ : apecsmeeting@gmail.com      
±³À°Á¾·ù : ¿µ»óÀÇÇаú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í »çÀüµî·Ï½Ã µî·Ïºñ ¹«·á ÇöÀåµî·Ï½Ã Àü¹®ÀÇ:3¸¸¿ø, ±âŸ:1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-25  09:00~09:10 What are common missing anatomies in US examination for venous disease?  À̰溹(¼­¿ïÀÇ·á¿ø) 
±³À°½Ã°£ 11-25  09:10~09:20 Which US equipment can be useful in venous clinics?  ±èÇâ°æ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-25  09:20~09:50 Live Case 1. : Thermal ablation  ¹Ú»ó¿ì,ȲÁøÈ£,¾ç¿ì¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  09:50~10:00 How to improve US imaging quality during the endovenous procedure  ±è°Ç¿ì(¹ÎÆ®º´¿ø) 
±³À°½Ã°£ 11-25  10:00~10:10 What are we missing when physicians handle US?  ±ÇÁö¿µ(ij³íÄÚ¸®¾Æ) 
±³À°½Ã°£ 11-25  10:10~10:20 Be the expert for US: How to obtain a license for US  È²Á¤±â(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-25  10:20~10:30 APECS meet IVDT symposium : Which benefits can IVDT give us?  Á¶ÁøÇö(°æÈñÀÇ´ë) 
È޽Ġ11-25  10:30~10:50 Coffee break  () 
±³À°½Ã°£ 11-25  10:50~11:05 Current trends for varicose vein treatment in Europe  Tibor Balazs(Medissimo Hospital Bratislava, Slovakia) 
±³À°½Ã°£ 11-25  11:05~11:15 EVLT is not a loser: Still developing and excellent result  ¾È»óÇö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-25  11:15~11:25 Recurrent CVI after surgery: Comparison of EVLT and RFA  È²ÁøÈ£(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  11:25~12:05 Live Case 2 : Venaseal  ¹Ú»ó¿ì,ȲÁøÈ£,¾ç¿ì¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  12:05~12:15 During thermal ablation for SSV: Can various saphenopopliteal junctional anatomy be obstacles?  ±è¿ì½Ä(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 11-25  12:15~12:25 Can endovenous procedure replace surgery completely? When we consider surgery?  ¹Î½Â±â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-25  13:05~13:45 ¿ä¾ç±Þ¿© ¹× º¸Çè±Þ¿© Áö±Þ ¿ä°Ç¿¡ °üÇÑ Á¦¹Ý ¹ý·ü °ËÅä-ÇÏÁöÁ¤¸Æ·ù¼ö¼ú °ü·Ã »ç·Ê¸¦ Áß½ÉÀ¸·Î  ¼ÛºÀÁÖ(¹ý¹«¹ýÀÎ ¼¼Á¾) 
±³À°½Ã°£ 11-25  13:45~13:50 How glue works in vessel  ÀåÀϼö(¼ö¿µ»óÀÇÇÐ) 
±³À°½Ã°£ 11-25  13:50~14:00 What do we need to focus on before, during, and after Venaseal treatment?  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 11-25  14:00~14:10 Can lower access for Venaseal reduce additional treatment for varicose tributaries  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  14:10~14:20 How does classic sclerotherapy work? Why does it fail to close the SV?  °øÁØÇõ(¸ÞµðÇ÷º½º¼¼Á¾º´¿ø) 
±³À°½Ã°£ 11-25  14:20~14:55 Live Case 3. : Clarivein  ¹Ú»ó¿ì,ȲÁøÈ£,¾ç¿ì¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  14:55~15:05 Mechanochemial ablation: What is difference from classic sclerotherapy and how to use it?  ±èº´±Õ(ºÎ»ê¼öÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-25  15:05~15:15 Big match comes true: Venaseal vs Clarivein  À̽Âö(ÆíÇÑÇÏÁöÈäºÎ¿Ü°ú) 
È޽Ġ11-25  15:15~15:30 Coffee break  () 
±³À°½Ã°£ 11-25  15:30~15:40 Which vein is better for PICC insertion?  ¿ÀÇàÁø(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-25  15:40~15:50 How do you select PICC catheter?  ½Éµ¿Àç(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-25  15:50~16:00 What do we need to do to keep perm-cath to be used long as a last resort?  ±è¿ëÀç(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 11-25  16:00~16:10 How to manage chemoport related complications?  ÀÌÀÎÁØ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 11-25  16:10~16:20 Single Incision technique for chemoport: Can everyone do it? (Video presentation)  ¼Û¸í±Ô(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-25  16:20~16:30 Central venous occlusion during central venous catheter insertion: How to manage it  ¹Ú±Ù¸í(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 11-25  16:30~16:40 New PICC catheter development: KUH research result  ¾ç¿ì¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  16:40~16:50 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °Ç±¹´ëÇб³º´¿ø Konkuk Live Symposium: APECS, 2018 : 2018-11-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°³¿øÀÇÇùÀÇȸ Á¦22Â÷ Ã߰迬¼ö±³À° Çмú¼¼¹Ì³ª : 2018-11-25
´ÙÀ½±Û Á¦5ȸ ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2018-11-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 692 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 740 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 864 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 797 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 816 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,148 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,110 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,072 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 986 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,229 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,523 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,393 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,202 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,428 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,979 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷